282 related articles for article (PubMed ID: 11872628)
21. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
[TBL] [Abstract][Full Text] [Related]
22. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
[TBL] [Abstract][Full Text] [Related]
23. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin.
Moser TL; Pizzo SV; Bafetti LM; Fishman DA; Stack MS
Int J Cancer; 1996 Sep; 67(5):695-701. PubMed ID: 8782661
[TBL] [Abstract][Full Text] [Related]
24. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity.
Morini M; Mottolese M; Ferrari N; Ghiorzo F; Buglioni S; Mortarini R; Noonan DM; Natali PG; Albini A
Int J Cancer; 2000 Aug; 87(3):336-42. PubMed ID: 10897037
[TBL] [Abstract][Full Text] [Related]
25. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
26. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer.
Cannistra SA; Ottensmeier C; Niloff J; Orta B; DiCarlo J
Gynecol Oncol; 1995 Aug; 58(2):216-25. PubMed ID: 7542622
[TBL] [Abstract][Full Text] [Related]
27. Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.
Thomas GJ; Hart IR; Speight PM; Marshall JF
Br J Cancer; 2002 Oct; 87(8):859-67. PubMed ID: 12373600
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.
Ahn SB; Mohamedali A; Anand S; Cheruku HR; Birch D; Sowmya G; Cantor D; Ranganathan S; Inglis DW; Frank R; Agrez M; Nice EC; Baker MS
J Proteome Res; 2014 Dec; 13(12):5956-64. PubMed ID: 25318615
[TBL] [Abstract][Full Text] [Related]
29. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.
Hahm K; Lukashev ME; Luo Y; Yang WJ; Dolinski BM; Weinreb PH; Simon KJ; Chun Wang L; Leone DR; Lobb RR; McCrann DJ; Allaire NE; Horan GS; Fogo A; Kalluri R; Shield CF; Sheppard D; Gardner HA; Violette SM
Am J Pathol; 2007 Jan; 170(1):110-25. PubMed ID: 17200187
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Alper O ; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG
J Natl Cancer Inst; 2001 Sep; 93(18):1375-84. PubMed ID: 11562388
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
[TBL] [Abstract][Full Text] [Related]
32. Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit.
Niu J; Dorahy DJ; Gu X; Scott RJ; Draganic B; Ahmed N; Agrez MV
Int J Cancer; 2002 Jun; 99(4):529-37. PubMed ID: 11992542
[TBL] [Abstract][Full Text] [Related]
33. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
34. Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement.
Festuccia C; Angelucci A; Gravina G; Eleuterio E; Vicentini C; Bologna M
Exp Cell Res; 2002 Oct; 280(1):1-11. PubMed ID: 12372334
[TBL] [Abstract][Full Text] [Related]
35. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
36. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
Tan X; Egami H; Nozawa F; Abe M; Baba H
Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
[TBL] [Abstract][Full Text] [Related]
38. Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via β1 integrin and PTEN signals.
Shen Y; Shen R; Ge L; Zhu Q; Li F
Int J Gynecol Cancer; 2012 Oct; 22(8):1316-24. PubMed ID: 23013730
[TBL] [Abstract][Full Text] [Related]
39. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
40. Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells.
Gu X; Niu J; Dorahy DJ; Scott R; Agrez MV
Br J Cancer; 2002 Jul; 87(3):348-51. PubMed ID: 12177807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
